Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

09/11/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Roland Sackers

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Qiagen NV (NYSE:QGEN)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025

Click aqui para mais gráficos Qiagen NV.

Qiagen NV (NYSE:QGEN)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025

Click aqui para mais gráficos Qiagen NV.

Notícias Qiagen NV

QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data
Quinta, 12 de Dezembro de 2024 (3 semanas atrás) • Business Wire

QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation
Quinta, 5 de Dezembro de 2024 (4 semanas atrás) • Business Wire

QIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing
Quinta, 28 de Novembro de 2024 (1 mês atrás) • Business Wire

QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis
Quarta, 27 de Novembro de 2024 (1 mês atrás) • GlobeNewswire Inc.

QIAGEN collaborates with McGill University to advance microbiome research
Terça, 12 de Novembro de 2024 (2 meses atrás) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Quinta, 7 de Novembro de 2024 (2 meses atrás) • Edgar (US Regulatory)

QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook
Quarta, 6 de Novembro de 2024 (2 meses atrás) • GlobeNewswire Inc.

QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics
Segunda, 4 de Novembro de 2024 (2 meses atrás) • GlobeNewswire Inc.

QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment
Terça, 29 de Outubro de 2024 (2 meses atrás) • GlobeNewswire Inc.

QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications
Quinta, 10 de Outubro de 2024 (3 meses atrás) • GlobeNewswire Inc.

QIAGEN N.V. to release results for Q3 2024 and hold webcast
Quinta, 10 de Outubro de 2024 (3 meses atrás) • GlobeNewswire Inc.

Global TB Summit 2024: QIAGEN leads the charge as tuberculosis reemerges as a leading infectious killer
Segunda, 7 de Outubro de 2024 (3 meses atrás) • GlobeNewswire Inc.

Mais Notícias de Qiagen NV

Índice Bovespa

Fictor Alimentos ON

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições